MET monthly performance report
Explore MET's monthly returns, drawdown, and seasonality trends — updated every month.
MET monthly report
—
Key takeaways
- MetLife (MET) closed September 2026 at $97.04, up 1.96% for the month and +22.73% over the trailing 12 months.
- Year-to-date, MET is +22.93%, outperforming the S&P 500 which has returned +11.70% YTD.
- The stock is trading +17.58% versus its 200-day moving average ($82.53), a bullish technical signal.
- Over the past three years, MET has underperformed the S&P 500 by −25.33%, with a relative strength index reading of 85.2.
- Win rate over the trailing 39 months stands at 59% — 23 positive months versus 16 negative months.
MetLife ended September 2026 at $97.04, posting a monthly return of +1.96%. The S&P 500 returned −0.70% over the same window, leaving relative performance at +2.66%.
The current quarter stands at +14.69% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +17.58% versus the 200-day moving average ($82.53).
Year-to-date, MET is +22.93% against SPY +11.70%, a gap of +11.23%. The stock is currently −3.85% below its 52-week high, with maximum 3-year drawdown at −23.29%.
| Period | MET | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.32% | −0.12% | −0.20% |
| 1 Week | −0.10% | −0.34% | +0.24% |
| 1 Month | +1.96% | −0.70% | +2.66% |
| 3 Months | +10.70% | +2.80% | +7.90% |
| 6 Months | +41.07% | +13.85% | +27.22% |
| YTD | +22.93% | +11.70% | +11.23% |
| 12 Months | +22.73% | +15.01% | +7.71% |
| 3 Years | +46.37% | +71.69% | −25.33% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jul 2026 | +13.62% |
| #2 | Apr 2026 | +13.26% |
| #3 | Nov 2024 | +12.51% |
| #4 | Jul 2023 | +11.39% |
| #5 | Jul 2024 | +9.49% |
| Rank | Month | Return |
|---|---|---|
| #1 | Feb 2026 | −8.63% |
| #2 | Dec 2024 | −7.20% |
| #3 | Mar 2025 | −6.83% |
| #4 | Apr 2025 | −6.13% |
| #5 | Jul 2025 | −5.56% |
| Quarter | Return |
|---|---|
| Q2 2025 | +0.16% |
| Q3 2025 | +2.42% |
| Q4 2025 | −4.16% |
| Q1 2026 | −10.41% |
| Q2 2026 | +19.64% |
| Q3 2026 (QTD) | +14.69% |
| Year | Return |
|---|---|
| 2023 | −8.62% |
| 2024 | +23.82% |
| 2025 | −3.59% |
| 2026 | +22.93% |
| Metric | Value |
|---|---|
| 52-Week High | $100.93 (2026-08-06) |
| 52-Week Low | $67.33 (2026-03-27) |
| Current Price | $97.04 |
| 200-Day Moving Average | $82.53 |
| Price vs 200DMA | +17.58% |
| 3-Year Maximum Drawdown | −23.29% (2026-03-27) |
| Current Drawdown from 52W High | −3.85% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 85.2 |
| 3-Year Excess Return vs S&P 500 | −25.33% |
| RS Peak | 100.8 (Sep 2023) |
| RS Trough | 68.7 (Mar 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was MET's return for this report period?
MET returned +1.96% in the latest monthly window ending 2026-09-18.
Has MET outperformed SPY year to date?
YTD MET: +22.93% vs SPY: +11.70%.
What is MET's 12-month return?
+22.73% over the trailing 12 months.
Is MET above or below its 200-day moving average?
Price is +17.58% versus 200DMA ($82.53).
What is the maximum drawdown in the 3-year window?
−23.29% on 2026-03-27.